arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Metagenomi Therapeutics, Inc.

MGX

$0.73 ▼ -0.07 (-8.54%) at close

15 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Metagenomi Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $27.5M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -25.6% ↘

FCF / Share $-0.52 ↗

Trailing P/E —

Price / Book 0.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

15-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.25M

↓ -69.8% —

Net Income Profit after all expenses

$-23.06M

↑ +7.9% —

Operating Margin Operating profit as % of sales

-263.8%

↓ -7.0% 0th

FCF / Share Free cash flow per share

$-0.52

↑ +7.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	—	-69.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-972%)	-59.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-841%)	-24.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-410%)	-57.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-818%)	-63.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-888%)	-22.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-381%)	-6.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-186%)	76.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+856%)	28.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+261%)	—	—	—	—	—
EPS Growth YoY (%)	-35.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	10.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	4.8% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-7.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-86.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	42.9% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	88.9% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	91.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	92.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	74.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	7.9% Fair ↑ Fair Improving Year-over-year change in net income	7.9% Fair ↑ Fair Improving Year-over-year change in net income	3.7% Caution ↑ Caution Improving Year-over-year change in net income	0.4% Caution ↑ Caution Improving Year-over-year change in net income	0.4% Caution ↑ Caution Improving Year-over-year change in net income	0.4% Caution ↑ Caution Improving Year-over-year change in net income	-21.3% Weak ↑ Weak Improving Year-over-year change in net income	-55.9% Weak → Weak Stable Year-over-year change in net income	-55.9% Weak Weak Year-over-year change in net income	-55.9% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	9.7% Fair Fair Year-over-year change in free cash flow	—	24.6% Good Good Year-over-year change in free cash flow	—	57.1% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	—	90.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	91.4% Excellent Excellent Year-over-year change in free cash flow	79.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	—	-47.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	—	—	—	-263.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1858%)	-246.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1744%)	—	-214.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1530%)	-194.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1396%)	-84.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-662%)	-260.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1834%)	-162.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1186%)	-181.1% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1308%)	-158.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1156%)	-207.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1481%)	—
Effective Tax Rate (%) (%)	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	17.0% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-16.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-17.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.8% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	-289.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2510%)	-294.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2551%)	—	-243.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2128%)	-218.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1920%)	-125.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1147%)	-225.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1978%)	-155.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1397%)	-130.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1187%)	-142.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1286%)	-186.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1653%)	—
FCF Margin (%) (%)	—	—	—	-246.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-276.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-241.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-134.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-275.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-180.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-210.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-257.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-273.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.22x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent → Excellent Stable Free cash flow relative to reported net income Optimal: > 1x	1.81x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.47x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-25.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	17.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	20035.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	20.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	16.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-16.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-7.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-5.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-20.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-212%)	-14.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-14.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-12.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-11.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-10.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-9.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-9.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-9.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	14.2% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-5%)	—	15.7% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	17.9% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+19%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Net Debt (USD)	$-39.03M	$-25.31M	$-41.72M	$-32.77M	$-26.85M	$-29.20M	$-27.39M	$-25.12M	$-61.18M	$-102.56M	$-140.60M	$-101.90M	$-51.65M	$-95.67M	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	—	$0.03	—	$0.23	$0.23	$0.11	—	$0.31	$0.55	$0.53	—	$3.63	$3.33	$2.54	—
Basic EPS, GAAP (USD)	$-0.73	$-0.61	$-0.60	$-0.55	$-0.54	$-0.68	$-0.63	$-0.51	$-0.29	$-1.19	$-5.67	$-5.82	$-3.82	$-4.74	—
Free Cash Flow per Share (USD)	$-0.52	$-0.56	—	$-0.57	—	$-0.62	—	$-0.76	$-0.74	$-1.46	—	$-7.63	$-8.59	$-6.95	—
Book Value per Share (USD)	$2.98	$3.66	$4.22	$4.75	$5.22	$5.69	$6.28	$6.96	$7.36	$7.36	$-39.82	$-0.03	$-30.12	$-26.44	—
Tangible Book Value per Share (USD)	$2.98	$3.66	$4.22	$4.75	$5.22	$5.69	$6.28	$6.96	$7.36	$7.36	$-39.82	$-0.03	$-30.12	$-26.44	—
Basic Weighted Avg Shares (shares)	37.66M	37.58M	—	37.35M	37.16M	37.02M	—	36.77M	36.63M	21.14M	—	3.40M	3.40M	3.40M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$96.84M	$122.06M	$142.60M	$160.24M	$178.42M	$193.30M	$220.65M	—	—	$264.94M	$209.41M	—	—	—	—
Total Equity (USD)	$112.57M	$137.78M	$158.60M	$178.45M	$195.83M	$212.66M	$234.86M	$255.77M	$269.42M	$275.63M	$-135.58M	$-119.02K	$-102.54M	$-90.01M	$-74.43M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	—	$1.25M	$3.91M	$8.66M	$8.51M	$4.13M	$9.61M	$11.51M	$20.01M	$11.16M	$12.40M	$12.36M	$11.34M	$8.66M	—
Depreciation Expense (USD)	$1.26M	$1.27M	$1.30M	$1.32M	—	$1.36M	$1.46M	$1.36M	$1.31M	$1.27M	$1.20M	$1.15M	$1.01M	$841.00K	—
Net Income, GAAP (USD)	$-23.06M	$-23.06M	$-22.53M	$-25.04M	$-25.04M	$-25.04M	$-23.40M	$-25.15M	$-25.15M	$-25.15M	$-19.29M	$-16.13M	$-16.13M	$-16.13M	—
Operating Cash Flow (USD)	$-19.51M	$-21.18M	$-23.55M	$-21.25M	—	$-22.84M	$-26.28M	$-26.64M	$-26.31M	$-29.85M	$-20.59M	$-23.73M	$-26.09M	$-21.00M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 15 quarters

Metagenomi Therapeutics, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MGX with peers